Ibnsina Pharma (ISPH) Net Income
Net Income
EGP 831.09M
Trailing 12 months (TTM)
As of 23 Jul 2026, 19:29 (Cairo time)
Net income is the profit remaining after all operating costs, interest and taxes are deducted from revenue — the bottom line of the income statement. A negative figure means the company recorded a loss for that fiscal year.
Net income history
| Fiscal year | Net income | YoY growth | Net margin |
|---|---|---|---|
| 2025 | 771.11M | 54.9% | 1.01% |
| 2024 | 497.8M | 187.51% | 0.89% |
| 2023 | 173.14M | 30.96% | 0.51% |
| 2022 | 132.21M | -53.83% | 0.59% |
| 2021 | 286.33M | 55.52% | 1.32% |
| 2020 | 184.11M | -39.27% | 0.99% |
| 2019 | 303.17M | 25.12% | 1.83% |
| 2018 | 242.3M | 42.41% | 1.82% |
| 2017 | 170.14M | 67.21% | 1.77% |
| 2016 | 101.75M | 77.39% | 1.41% |
| 2015 | 57.36M | — | 1.08% |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.